GSK update regarding Pfizer Inc. Consumer Healthcare
GlaxoSmithKline plc (LSE/NYSE: GSK) today confirms it has withdrawn from the process relating to Pfizer’s Consumer Healthcare business.
Emma Walmsley, Chief Executive Officer, GSK said:
“While we will continue to review opportunities that may accelerate our strategy, they must meet our criteria for returns and not compromise our priorities for capital allocation.”
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit about us.
Find out more
We are a science-led global healthcare company with a special purpose to improve the quality of human life.